Editorial: Molecular biomarkers in hepatobiliary and pancreatic cancers: implications of non-coding RNAs and its therapeutic opportunities
Front Med (Lausanne)
.
2023 Jul 26:10:1247320.
doi: 10.3389/fmed.2023.1247320.
eCollection 2023.
Authors
Souvick Roy
1
,
Milad Moloudizargari
2
,
Caiming Xu
3
Affiliations
1
Moores Cancer Center, University of California, San Diego, La Jolla, CA, United States.
2
Beckman Research Institute, City of Hope, Duarte, CA, United States.
3
Department of General Surgery, First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, China.
PMID:
37564042
PMCID:
PMC10411181
DOI:
10.3389/fmed.2023.1247320
No abstract available
Keywords:
hepatobiliary cancer; molecular biomarker; non-coding RNAs; pancreatic cancer; prognosis.
Publication types
Editorial